These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2888790)

  • 1. Short-term effects of beta blockers atenolol, nadolol, pindolol, and propranolol on lipoprotein metabolism in normolipemic subjects.
    Harvengt C; Heller FR; Martiat P; Van Nieuwenhuyze Y
    J Clin Pharmacol; 1987 Jul; 27(7):475-80. PubMed ID: 2888790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of adrenergic blockade on lipoproteins using the rat as an experimental model.
    Balasubramaniam S; Simons LA; Hickie JB; Chang S
    Artery; 1990; 17(2):60-70. PubMed ID: 1968740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term effects of beta-adrenoceptor blocking drugs with and without cardioselectivity and intrinsic sympathomimetic activity on lipoprotein metabolism in hypertriglyceridaemic patients and in normal men.
    Durrington PN; Brownlee WC; Large DM
    Clin Sci (Lond); 1985 Dec; 69(6):713-9. PubMed ID: 2866062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-adrenergic antagonist inhibition of hepatic 3,5,3'-triiodothyronine production.
    Shulkin BL; Peele ME; Utiger RD
    Endocrinology; 1984 Sep; 115(3):858-61. PubMed ID: 6146516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of chronic oral administration of a new beta-blocker, bopindolol, on serum lipoprotein concentrations and blood pressure of spontaneously hypertensive rats.
    Ishihara T; Chin WP; Yoshida Y; Sun HT; Mitomi A; Ishibashi T; Tamura K; Imai S
    Arch Int Pharmacodyn Ther; 1989; 302():145-57. PubMed ID: 2576891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of beta blockers on blood lipid profile.
    Lehtonen A
    Am Heart J; 1985 May; 109(5 Pt 2):1192-6. PubMed ID: 2859784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-blockade with intrinsic sympathetic activity modifies favorably exercise-induced changes in plasma lipoproteins.
    Van Nguyen P; Cleroux J; Peterson M; Leenen FH
    J Appl Physiol (1985); 1990 Aug; 69(2):485-9. PubMed ID: 1977731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of indapamide and various diuretics alone or combined with beta-blockers on serum lipoproteins.
    Weidmann P; Bianchetti MG; Mordasini R
    Curr Med Res Opin; 1983; 8 Suppl 3():123-34. PubMed ID: 6137325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of beta-blockers on plasma lipids during antihypertensive therapy.
    Lehtonen A
    J Cardiovasc Pharmacol; 1985; 7 Suppl 2():S110-4. PubMed ID: 2409357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of beta-blocker effects on serum lipids and apolipoproteins in hypertensive patients with normolipidaemic or dyslipidaemic profiles.
    Vyssoulis GP; Karpanou EA; Pitsavos CE; Skoumas JN; Paleologos AA; Toutouzas PK
    Eur Heart J; 1992 Nov; 13(11):1506-13. PubMed ID: 1361175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Class III action of beta-blocking agents.
    Taggart P; Donaldson R; Abed J; Nashat F
    Cardiovasc Res; 1984 Nov; 18(11):683-9. PubMed ID: 6149809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of alpha- and beta-adrenergic antagonists on plasma apolipoproteins and forearm blood flow in patients with mild hypertension.
    Sacks FM; Creager MA; Gallagher SJ; Loscalzo J; Dzau VJ
    Am J Med; 1989 Jan; 86(1B):8-13. PubMed ID: 2563311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of beta-blockers on the concentration and oxidizability of plasma lipids.
    Dimmitt SB; Williams PD; Croft KD; Beilin LJ
    Clin Sci (Lond); 1998 Jun; 94(6):573-8. PubMed ID: 9854453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of liver lipase. II. Involvement of the alpha 1-receptor.
    Schoonderwoerd K; Hülsmann WC; Jansen H
    Biochim Biophys Acta; 1984 Oct; 795(3):481-6. PubMed ID: 6148107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of selective and nonselective beta-adrenergic blockade on mechanisms of exercise conditioning.
    Wolfel EE; Hiatt WR; Brammell HL; Carry MR; Ringel SP; Travis V; Horwitz LD
    Circulation; 1986 Oct; 74(4):664-74. PubMed ID: 2875812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the short-term beta-adrenoceptor blockade on exercise metabolism in cold weather.
    Lehtonen A; Huupponen R; Himanen P
    Int J Clin Pharmacol Ther Toxicol; 1984 Feb; 22(2):86-90. PubMed ID: 6142007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central propranolol and pindolol, but not atenolol nor metoprolol, inhibit sexual behavior in male rats.
    Smith ER; Kacker SR; Raskin A; Yun PT; Davidson JM; Hoffman BB; Clark JT
    Physiol Behav; 1996 Feb; 59(2):241-6. PubMed ID: 8838601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of four beta-adrenoceptor antagonists during modest exercise on plasma ammonia and heart rate.
    Hall PE; Smith SR; Kendall MJ
    Clin Sci (Lond); 1987 Jun; 72(6):679-82. PubMed ID: 2885122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in plasma activities of lipolytic enzymes and lipids of normolipidemic subjects given phenobarbital, a strong microsomal inducer, alone or in combination with fenofibrate.
    Heller FR; Desager JP; Harvengt C
    Int J Clin Pharmacol Ther Toxicol; 1988 Mar; 26(3):138-42. PubMed ID: 3410596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cetamolol: cardiovascular effects of a new cardioselective beta-adrenoceptor blocker possessing partial agonistic activity and lacking membrane-stabilizing activity.
    Beaulieu G; Grimes D; Muirhead C; Oshiro G
    Can J Physiol Pharmacol; 1984 Jun; 62(6):610-6. PubMed ID: 6146394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.